Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations

Sylvie Freeman, Robert Hills, Paul Virgo, Naeem Khan, S. Couzens, Richard Dillon, Amanda Gilkes, Laura Upton, Ove Juul Nielsen, James D Cavenagh, Gail Jones, Asim Khwaja, Paul Cahalin, Ian Thomas, David Grimwade, Alan K Burnett, Nigel H Russell

Research output: Contribution to journal › Article › peer-review

73 Citations (Scopus)
166 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences